Grant updates

Find out about new funding calls, where your application is in the process, and upcoming deadlines.

5 min read - 30 Oct 2026

page a day calendar

Applications in progress

All-Ireland Cancer Consortium Research & Innovation Grants Scheme 2026 ‘Survivorship-Living Well With & Beyond Cancer’

The All-Ireland Cancer Consortium 2026 Scheme opened on 25 Feb 2026 and closed for applications on 27 May 2026 at 13:00. An information webinar took place on 24 March and the recording is available here.

The AICC 2026 call targets funding to support cancer research focused on survivorship, for people living well with and beyond a cancer diagnosis. Cancer survivorship research covers the period from diagnosis to treatment outcome and seeks to improve care and outcomes experienced by people living with and past cancer. It will enable support of cross-border cooperation and joint efforts in cancer survivorship research to ultimately benefit people, living across the island of Ireland and beyond.

The outcome following peer/public review were issued on 17 August with shortlisted applicants invited to submit a response to review comments. Applications are currently under review by the International Review Panel and outcomes will be communicated in  December following HRB Board approval.

Investigator-led Clinical Trials (ILCT) Programme 2025 (formerly DIFA)

The Cycle 3 Review Panel meeting was held in early October. Outcomes will be communicated in early December 2026, following HRB Board approval.

Collaborative Postdoctoral Fellowships Programme (CPFP) 2026

The panel review phase is currently ongoing, followed by interviews on 10 and 11 November 2026. Final outcomes are expected in mid-December.

European Partnership for Personalised Medicine (EPPerMed) Research, Innovation and Technology Call (RITC) 2026

The “Test and Demonstration of Multimodal Data Approaches for Personalised Medicine (MultiPMData2026)’ RITC call has two stages for applicants, both of which have now closed. Outcome results have been shared, and applicants should engage with the HRB regarding the next steps.

European Rare Diseases Research Alliance (ERDERA) Joint Transnational Call (JTC) 2026 

‘Resolving unsolved cases in rare genetic and non-genetic diseases’ is the ERDERA JTC 2026 call topic. Full proposals are currently undergoing review. Outcomes will be released towards the end of the year.

European Partnership on One Health Antimicrobial Resistance (OHAMR) 2026

The deadline for submitting full proposals has passed, and full proposals are currently under review. The overall outcome results are expected by the end of October.

The Applied Partnership Awards –   ’s Health (APA-WH) 2026

Following the review process 10 applications were approved for funding by the HRB Board.

Open Calls

US-Ireland Research and Development Partnership Programme

This is a rolling call. The call guidance has been updated and can be found here.  Check the scheme notice for full details – US-Ireland R&D Partnership Programme.

Summer Student Scholarships (SS) 2027

The scholarship scheme offers undergraduates studying a level 8 degree an opportunity to undertake a health or social care research project and to work with researchers in high-quality research environments to gain research experience at an early stage in their career. The call will close on Thursday 12 November at 13.00.

Impact Award (IMPACT) 2027

The HRB Impact Award recognises and celebrates the achievements of HRB-funded researchers whose work has delivered benefits beyond academia. It highlights research that has influenced policy, practice, health services, or the wider health and social care system, leading to improved health outcomes, quality of life, and experiences for patients, communities, organisations, and the public. The call for nominations will close on 19 November at 13:00. Applications are by nomination only.

ERA4Health Partnership 

ERA4Health has launched the 2027 joint transnational call titled “Multi-national Investigator-Initiated Clinical Studies in Cardiovascular, Autoimmune, Metabolic, and Non-Communicable Respiratory Diseases, including Underrepresented Populations”.

The aim of the call is to support pragmatic, phase III, randomised controlled, multi-national interventional Investigator-Initiated Clinical Studies (IICS), designed as either comparative effectiveness studies or drug repurposing studies, in the areas of cardiovascular diseases, metabolic disorders, autoimmune diseases and non-communicable respiratory diseases.

See the call website for full details: IICS4all 2027 | ERA4Health Joint Transnational Call. The deadline for pre-proposal submission is 14 January 2027.

An information webinar will take place on 10 November 2026 (a link to register is available on the call website).

Guidance for applicants based in Ireland will be available on the HRB website shortly.

Other European research funding opportunities 

See our EU funding updates story for information on more European research funding opportunities.

See also general information on the Horizon Europe and EU4Health programmes.

Upcoming calls

European Partnership on Transforming Health and Care Systems (THCS) 2027

The HRB are participating in the 2027 joint transnational call entitled “Transforming the Health and Care Workforce for Sustainable and Resilient Systems”. The call will launch on 16 November 2026 with a deadline for pre-proposal submission of 21 January 2027.

An information webinar will take place on 2 December 2026 (13.30–15.30). Details of the webinar and guidance for applicants based in Ireland will be published on HRB’s webpage shortly after the call launches.

European Rare Diseases Research Alliance (ERDERA) Joint Transnational Call (JTC) 2027 Pre-announcement

The 2027 joint transnational call titled “Catalysing Collaborative Research for Recently Identified Rare Diseases” has been pre-announced to launch on 22 October 2026. The call aims to stimulate research interest and catalyse new collaborative initiatives centred on recently identified RDs that remain scientifically underserved. By advancing the understanding of natural history and disease pathomechanisms, and by fostering the development of relevant disease models, the overarching aim is to generate the foundational knowledge required to accelerate future therapeutic development.

An information webinar will occur on 14 December 2026 with pre-proposal submission closing on 01 Feb 2027. Applicants from Ireland should refer to the HRB call webpage after the call launches. For further information see also: ERDERA JTC 2027

European Partnership on One Health Antimicrobial Resistance (OHAMR) 2027

The European Partnership on OHAMR has pre-announced the 2027 joint transnational call entitled “Understand, Model and Stop AMR Transmission”. It will launch on 18 November 2026 with a deadline for pre-proposal submission of 1 February 2027.

An information webinar will take place on 25 November 2026 (12:30–14:30 GMT). Details of the webinar and guidance for applicants based in Ireland will be published on HRB’s webpage shortly after the call launches.

 

5 min read - 30 Oct 2026

Related Articles